Dr. Dinesh Pendharkar

• FASCO: Fellow of the American Society of Clinical Oncology
• Inspiring Oncologist of India: Times Now ET Edge Award
• Lifetime Achievement Award: Indian Society of Oncology (ISO) – 2022
• S H Advani Oration – Jaipur 2018
• Special Appreciation Award, Govt of Odisha – 2017
• SK Mukherjee-Physician Recognition Award, Indore – 2016
• Physician Recognition Award – Govt of Madhya Pradesh, 2016
• Pt. P.K. Shankhdhar Memorial Oration, Lucknow – 2002
• Oration – Indian Society of Medical & Paediatric Oncology (ISMPO) – 2006
• SIOP Award 2002 (Co-author, International Society of Paediatric Oncology)
• Various Study Grants (PhD, MD Indo-USSR), Travel Grants (CSIR, DST), Fellowships (Pharmacia-Upjohn BMT, DST Laser).

• Marqui’s Who’s Who in Medicine and Healthcare 2006-2007
• Distinguished Doctor Award – DMA 2005
• Past President – ISO & ISMPO
• Past Chair – ASCO International Affairs Committee & MCMC Working Committee
• Extensive international recognition through Visiting Professorships and advisory roles.

• Novel and effective management of capecitabine induced hand foot syndrome (ASCO Proceedings, 2004)
• Multiple publications/presentations on the District Cancer Care Programme (Pendharkar Model) and its outcomes (ASCO, J Can Res Ther)
• Publications on Sickle Cell Disease (HbF status, BMT review, KAP study) in JPPCH (2023)
• ASCO Educational Book chapters (2017, 2020) on Global Oncology & Empowering Workforce.
• Autologous peripheral stem cell transplant in non-Hodgkin’s lymphoma (JAPI, 1998 – documenting rural BMT)
• Multiple abstracts presented at ASCO, ASH, ESMO, ECCO, SIOP etc. on various topics (Nimotuzumab toxicity, EPO levels, G-CSF kinetics, lymphoma classifications, etc.)

• Chapter: Making the best use of resources in Global Cancer Care (ASCO Educational Book, 2020)
• Chapter: Thinking differently in global health in oncology…empowering and alternative oncology workforce (ASCO Educational Book, 2017)
• Chapter: Double refractory myeloma: Management (Haematology Today, 2015)
• Chapter: Breast cancer in Young women (Converge Breast Cancer Update, 2014)
• Book: Targeted Therapy, Reference book for physicians (MET, 2013)
• Associate Editor: Reference Manual for National training project- Practical Paediatric Oncology (PHO Chapter, IAP, 1998)

• ICH GCP Certified with extensive past experience as PI/Co-I in numerous trials (list provided includes Gleevec bioequivalence, Tarceva EAP, Pegfilgrastim, Myocet, Caspofungin, Filgrastim trials). Continues research activities, particularly in healthcare delivery science and Sickle Cell Disease.

• Pioneered BMT in a rural setting, demonstrating feasibility with limited resources.
• Successfully managed countless patients with complex hematological malignancies and solid tumours over four decades.
• Led the establishment of a state-of-the-art, NABH-accredited BMT unit at Sarvodaya Hospital.
• Spearheaded the District Cancer Care Programme, impacting thousands of patients in underserved areas.
• Developed effective strategies for managing debilitating side effects like Hand-Foot Syndrome.

“Dr. Pendharkar is a legend in Indian oncology. His experience is vast, but his approach is humble and reassuring. He guided my family through my BMT process with utmost care and professionalism. We felt secure knowing we were under one of the best.” – A. Kumar “I highly recommend Dr. Dinesh Pendharkar as a cancer specialist.” – S. Shaan “Dr. Pendharkar’s research and recommended treatment provided immense relief when nothing else worked. His dedication to improving patient quality of life alongside fighting cancer is remarkable.” – R. Patel